Weight-loss drugs like Ozempic, Wegovy and Rybelus are markedly more expensive in the US than in other wealthy countries — up to 10 times more. An analysis of prices in 10 countries by the Kaiser ...

Novo Nordisk (NVO) is reportedly suing several medical spas and wellness clinics for allegedly selling medications that they claimed were customized versions of Novo's GLP-1 drugs, which have become ...

Rybelsus (semaglutide) has Food and Drug Administration (FDA) approval to manage blood sugar levels in adults with type 2 diabetes. Interested in learning more about it? You’re not alone—many people ...

Weight-loss jabs and those for diabetes may be linked to a lower risk of dementia, a study suggests. Semaglutide in particular, whose brand names include Wegovy and Ozempic, showed promise in cutting ...